Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analog of the C-terminal heptapeptide with .epsilon.-hydroxynorleucine sulfate replacing tyrosine sulfate

Abstract
The influence of tyrosine O-sulfate, the 27th residue in the sequence of cholescystokinin (pancreozymin) (CCK-PZ), on the contraction of gall bladder of guinea pigs and on the release of amylase in isolated pancreatic cells of the same animal was studied with an analog of the biologically active C-terminal heptapeptide, CCK-PZ-(27-33). In the new analog, tyrosine O-sulfate was replaced by .epsilon.-hydroxynorleucine O-sulfate. The synthetic peptide was found a full agonist in these tests, not quite as potent as the unaltered heptapeptide, but much more active than the previously prepared and studied serine O-sulfate containing analog. Apparently the distance of the sulfate ester group from the peptide backbone has a major influence on the biological activity of CCK-PZ.

This publication has 11 references indexed in Scilit: